RSNA 2018 Monday — AI and Enterprise Imaging Gain Traction

Among two of the top trends brewing on theRadiological Society of North America (RSNA) 2018 meetingexhibit floor areartificial intelligence (AI)and enterprise imaging. New, old and unconventional vendors promote one, the other or both in new offerings on the exhibit floor.

Picking IcoMetrix’s (Ico) Brain

在计算机断层扫描(CT)中寻找脑损伤的迹象?比利时的icometrix公司展示了其获得fda批准的icobrain可以提供的帮助。该公司在其展台(北厅7367)的机器学习展示会上介绍了其icobrain产品内置的深度学习算法如何分析CT图像，以表征创伤性脑损伤。Icometrix正在推广一种商业化的临床CT产品，以帮助医生管理怀疑有创伤性脑损伤的患者。该产品使用深度学习来量化典型的定性图像成分，如CT图像中的高密度体积、基底池的压缩和中线脑位移，每一种都可能不仅表明头部损伤的存在，而且表明其严重程度。

Change Promotes Products/Expertise In Enterprise Imaging

孤立的医学学科正在寻找连接的方法，Change Healthcare正在推动路线图，带领用户绕过企业成像的障碍。在其展位(北6713号馆)，Change正在推广一种开放的方式，包括三个组成部分:自身的产品;第三方软件;以及内部专业知识，让他们一起工作。Change Healthcare的企业组合转换执行董事Todd Johnson表示，成功的企业映像的关键是确定目标并制定实现这些目标的路径。该公司正在展示它的通用视图，它是粘合企业映像无数组件的粘合剂，以及它的工作流智能产品线，它是编排工作流的引擎。

Imalogix Shows How AI Can Improve Imaging

Imalogix is demonstrating at its booth (South Hall 2305) how deep learning algorithms can improve imaging techniques. One exemplary case involves centering. Imalogix chairman and CEO John Heil explains that if a scan is “off center,” for example, patients may be exposed to as much as 50 percent more radiation than necessary. The company is demonstrating how its algorithms reveal whether “centering” needs to be changed and how to change it.

Similarly, deep learning algorithms may help sites get more from their equipment by comparing utilization. Improved efficiency is the common denominator of both. When it comes to centering, patients may benefit by being assured they get minimal but sufficient radiation dose, Heil says. The bottom line in both is how AI can improve the delivery of care, as DL algorithms establish benchmarks against which performance at the user site can be compared.

Guerbet Reinvents Itself With AI

Best known as a supplier of contrast media, Guerbet is shining a multivariate light on digital solutions. One source of illumination is coming from in-house work; others from Imalogix and IBM Watson Health. In its booth in South Hall (2558), Guerbet is demonstrating three technologies. One is the latest version of its Contrast and Care software, which is designed to improve productivity and traceability of Guerbet contrast media. A second is from Imalogix, the vendor neutral Radiation Dose Solution, which tracks patient exposure to ionizing radiation, using deep learning to mine data and compare dosing at a customer’s facility to that of other facilities. The third is an AI tool developed by IBM Watson Health, a tool called Watson Imaging Patient Synopsis, which summarizes patient information into single-view reports. Guerbet is demonstrating the tool, which it plans to distribute under a reseller agreement, as it continues working jointly with IBM Watson Health to develop AI software to support liver cancer diagnosis and care.

Read more in the article "Guerbet Partners With Imalogix on Dose Optimization With Artificial Intelligence."

Arterys Promotes Practical AI

Fresh off FDA clearance is an AI system that detects tumors and heart problems.At its booth in (North Hall 7964) within the Machine Learning Showcase, Arterys presents Cardio AIMR (referred to as “Cardio DL” in the FDA filing). The newly cleared product analyzes MR images to indicate cardiovascular blood flow. Federal regulators classified the technology as a “support tool” for clinical decision-making by licensed healthcare practitioners, stating that it is “not intended to be a source of medical advice or to determine or recommend a course of action or treatment.” Also showing at the Arterys booth are AI-based tools that measure and track: liver lesions (Liver AI) and lung nodules (Lung AI); Viewer, which is designed to accelerate the display and reading of medical images; and Breast AI for mammography to support the display of mammograms using the Google Chrome web browser.

Read more in the article "Arterys Demonstrates AI Cloud-Based Medical Image Analysis Solutions at RSNA 2018."

FDA-cleared App Detects Brain Bleeds

MaxQ AI's Accipio Ix intracranial hemorrhage (ICH) detection software received FDA 510(k) clearance to aid in prioritizing the clinical assessment of adult non-contrast head CT cases that exhibit indications of intracranial hemorrhage (ICH), commonly known as a brain bleed. The software leverages artificial intelligence technology to automatically analyze non-contrast head CT images without workflow impact to the reader. The software can be integrated into a PACS or directly into a CT scanner in the emergency department for a first pass read of stroke patients.

View three VIDEO examples of how this software detects brain bleeds.

阅读fda对该产品的许可。

Related RSNA 2018 Coverage:

RSNA 2018 Sunday – Improving, Not Replacing

VIDEO: RSNA President Says Artificial Intelligence is Hottest Tech Advancement in Radiology.

PODCAST Hear and Now: What You Need to Know About Enterprise Imaging

PODCAST Hear and Now: Intervention Rising

PODCAST: What You Need To Know About Enterprise Imaging